Markets Mubadala trims stake in Portuguese telco By Megha Merani May 2, 2025, 1:30 AM Alamy via Reuters NOS headquarters, Lisbon. While increasing its European tech and telecom investments elsewhere, Mubadala has decreased its shareholding in the Portuguese operator Mubadala Investment Company, Abu Dhabi’s $300 billion sovereign wealth fund, has trimmed its holding in Portuguese telecoms operator NOS SGPS. ATIC Second International Investment, a Mubadala subsidiary, reduced its stake from 5 percent to 3.2 percent, according to a regulatory filing by NOS to the Portuguese Securities Market Commission. No reason was given for the divestment. NOS, Portugal’s second largest telecom provider after MEO (Altice Portugal), offers fixed and mobile services, television and internet. It is listed on Euronext Lisbon. Mubadala and Fortress form $1bn private credit partnership US-driven trade war forces Mubadala to change ‘assumptions’ Abu Dhabi AI chief bullish over future investment Mubadala has in recent years increased its exposure to European technology and telecom assets, investing in fibre networks and data centres through stakes in Sweden-based GlobalConnect, UK-based hyperscale developer Yondr Group and Babel, a Madrid-based IT and digital transformation provider. Mubadala has also invested around $1 billion in CityFibre, the UK’s largest independent full-fibre platform. NOS shares closed 0.27 percent higher at €3.675 on April 30. Register now: It’s easy and free AGBI registered members can access even more of our unique analysis and perspective on business and economics in the Middle East. Why sign uP Exclusive weekly email from our editor-in-chief Personalised weekly emails for your preferred industry sectors Read and download our insight packed white papers Access to our mobile app Prioritised access to live events Register for free Already registered? Sign in I’ll register later Register now: It’s easy and free AGBI registered members can access even more of our unique analysis and perspective on business and economics in the Middle East. Why sign uP Exclusive weekly email from our editor-in-chief Personalised weekly emails for your preferred industry sectors Read and download our insight packed white papers Access to our mobile app Prioritised access to live events Register for free Already registered? Sign in I’ll register later
